These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29466294)

  • 21. Hepatic resection of hepatocellular carcinoma after proton beam therapy: A case report.
    Kinjo N; Ikeda Y; Taguchi K; Sugimoto R; Maehara S; Tsujita E; Kawano H; Yamaguchi S; Egashira A; Minami K; Yamamoto M; Morita M; Toh Y; Okamura T
    Hepatol Res; 2016 Mar; 46(5):483-8. PubMed ID: 26286377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
    Yoo GS; Yu JI; Park HC; Hyun D; Jeong WK; Lim HY; Choi MS; Ha SY
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
    Sekino Y; Okumura T; Fukumitsu N; Iizumi T; Numajiri H; Mizumoto M; Nakai K; Nonaka T; Ishikawa H; Sakurai H
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):711-720. PubMed ID: 31776663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image-Guided Proton Therapy for Elderly Patients with Hepatocellular Carcinoma: High Local Control and Quality of Life Preservation.
    Iwata H; Ogino H; Hattori Y; Nakajima K; Nomura K; Hayashi K; Toshito T; Sasaki S; Hashimoto S; Mizoe JE; Shibamoto Y
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma.
    Kim TH; Park JW; Kim BH; Kim DY; Moon SH; Kim SS; Lee JH; Woo SM; Koh YH; Lee WJ; Kim CM
    Oncotarget; 2018 Jan; 9(3):4034-4043. PubMed ID: 29423102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.
    Hata M; Tokuuye K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Ohara K; Matsuzaki Y; Tanaka N; Akine Y
    Cancer; 2005 Aug; 104(4):794-801. PubMed ID: 15981284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
    Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
    Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective study of late adverse events in proton beam therapy for prostate cancer.
    Makishima H; Ishikawa H; Tanaka K; Mori Y; Mizumoto M; Ohnishi K; Aihara T; Fukumitsu N; Okumura T; Sakurai H
    Mol Clin Oncol; 2017 Oct; 7(4):547-552. PubMed ID: 29046789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis.
    Kim DY; Park JW; Kim TH; Kim BH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim CM
    Radiother Oncol; 2017 Jan; 122(1):122-129. PubMed ID: 28034460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful two-stage operation for esophageal necrosis due to proton beam therapy followed by sorafenib in a case of large hepatocellular carcinoma.
    Higaki E; Fukaya M; Miyata K; Kawai R; Abe T
    Surg Case Rep; 2020 Jun; 6(1):138. PubMed ID: 32548687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
    Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.
    Nakajima K; Iwata H; Ogino H; Hattori Y; Hashimoto S; Toshito T; Hayashi K; Akita K; Baba F; Nakamae K; Mizoe JE; Shibamoto Y
    Radiat Oncol; 2018 Oct; 13(1):199. PubMed ID: 30305125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton beam therapy for aged patients with hepatocellular carcinoma.
    Hata M; Tokuuye K; Sugahara S; Tohno E; Nakayama H; Fukumitsu N; Mizumoto M; Abei M; Shoda J; Minami M; Akine Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):805-12. PubMed ID: 17524568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
    Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
    Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis.
    Mizumoto M; Tokuuye K; Sugahara S; Nakayama H; Fukumitsu N; Ohara K; Abei M; Shoda J; Tohno E; Minami M
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):462-7. PubMed ID: 18243571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three cases of hepatocellular carcinoma treated 4 times with proton beams.
    Murakami M; Fukumitsu N; Okumura T; Numajiri H; Murofushi K; Ohnishi K; Mizumoto M; Ishikawa H; Tsuboi K; Sakurai H
    Mol Clin Oncol; 2020 Jan; 12(1):31-35. PubMed ID: 31814974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary results of proton-beam therapy for stage III non-small-cell lung cancer.
    Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yamaguchi H; Hayashi Y; Tsukiyama I; Hareyama M; Kikuchi Y; Takai Y
    Curr Oncol; 2015 Oct; 22(5):e370-5. PubMed ID: 26628878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.